Loading...

Home
Stock
INZY

INZY News & Events

-

$

0.000

0.000(0.000%)1D

Overview Forecast Valuation Earnings News

Loading...

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Select market data provided by Financial Markets Infrastructure and Data|LSEG

Broker connection service provided by Connect to brokerage accounts for data and trading SnapTrade

Company

Home
Contact
About Us
News Release

Market

Market Analysis
Crypto
Market Movers
Stock Monitor
All US Stocks

Strategies

AI Stock Picker
Swing Trading
QuantAI Alpha Pick
CoinSwing
Daytrading Radar
Crypto Radar
Char Pattern Detection

Resource

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat with Tia
AI Screener
Backtesting Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Option Profit Calculator

Features

AI Stock Picker
Swing Trading
QuantAI Alpha Pick
Whales Auto Tracker
Daytrading Center
Patterns Detection
Financial AI Agent
AI Screener
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Stock Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Monitor News

Compare

TradingView
Seeking Alpha

INZY News

BioMarin Announces Completion of Acquisition of Inozyme

Jul 01 2025Newsfilter

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INZY, SVT, HLGN on Behalf of Shareholders

Jun 12 2025PRnewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INZY, TXNM, SVT, PTIX on Behalf of Shareholders

May 27 2025Globenewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Inozyme Pharma, Inc. (Nasdaq – INZY), TXNM Energy, Inc. (NYSE - TXNM), Servotronics, Inc. (NYSE American - SVT), Protagenic Therapeutics, Inc. (Nasdaq – PTIX)

May 27 2025Globenewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVDX, TASK, INZY on Behalf of Shareholders

May 22 2025PRnewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TXNM, SVT, INZY, PTIX on Behalf of Shareholders

May 19 2025PRnewswire

Wells Fargo Maintains Equal-Weight on Inozyme Pharma, Lowers Price Target to $4

May 19 2025Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Inozyme Pharma, Inc. (Nasdaq – INZY), TXNM Energy, Inc. (NYSE - TXNM), Servotronics, Inc. (NYSE American - SVT), Protagenic Therapeutics, Inc. (Nasdaq – PTIX)

May 19 2025Globenewswire

INZY Events

CervoMed Names Matthew Winton as Chief Commercial and Business Officer

CervoMed (CRVO) announced the appointment of Matthew Winton, Ph.D., as Chief Commercial and Business Officer. Before joining CervoMed, Dr. Winton served as COO at Inozyme Pharma (INZY).

Sixteen option delistings on July 22nd

Option delistings effective July 22nd include Radius Recycling, Inc. - Class A Common Stock (RDUS), PHX Minerals Inc. (PHX), LSEA Stock (LSEA), KRON Stock (KRON), Juniper Networks, Inc. (JNPR), INZY Stock (INZY), HARTFORD SCHRODERS COMMODITY STRATEGY ETF (HCOM), EVRI Stock (EVRI), Enstar Group Limited - Ordinary Shares (ESGR), Dada Nexus (DADA), GRANITESHARES 1X SHORT AMD DAILY ETF (AMDS), AGS Stock (AGS), RGLS Stock (RGLS), SWTX Stock (SWTX), WisdomTree Battery Value Chain and Innovation Fund (WBAT), and X Stock (X).

INZY Monitor News

an image of No data

No data

INZY Earnings Analysis

an image of undefined

People Also Watch